| Product Code: ETC12011454 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Drug Repurposing Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Drug Repurposing Market - Industry Life Cycle |
3.4 Austria Drug Repurposing Market - Porter's Five Forces |
3.5 Austria Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.6 Austria Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.7 Austria Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Austria Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Austria Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Austria Drug Repurposing Market Trends |
6 Austria Drug Repurposing Market, By Types |
6.1 Austria Drug Repurposing Market, By Approach |
6.1.1 Overview and Analysis |
6.1.2 Austria Drug Repurposing Market Revenues & Volume, By Approach, 2021 - 2031F |
6.1.3 Austria Drug Repurposing Market Revenues & Volume, By On-Target Repurposing, 2021 - 2031F |
6.1.4 Austria Drug Repurposing Market Revenues & Volume, By Off-Target Repurposing, 2021 - 2031F |
6.1.5 Austria Drug Repurposing Market Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031F |
6.1.6 Austria Drug Repurposing Market Revenues & Volume, By Pathway-Based Repurposing, 2021 - 2031F |
6.2 Austria Drug Repurposing Market, By Disease Area |
6.2.1 Overview and Analysis |
6.2.2 Austria Drug Repurposing Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Austria Drug Repurposing Market Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031F |
6.2.4 Austria Drug Repurposing Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.5 Austria Drug Repurposing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3 Austria Drug Repurposing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Austria Drug Repurposing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Austria Drug Repurposing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.4 Austria Drug Repurposing Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.5 Austria Drug Repurposing Market Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031F |
6.4 Austria Drug Repurposing Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Austria Drug Repurposing Market Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031F |
6.4.3 Austria Drug Repurposing Market Revenues & Volume, By High-Throughput Screening, 2021 - 2031F |
6.4.4 Austria Drug Repurposing Market Revenues & Volume, By Biomarker-Based Repurposing, 2021 - 2031F |
6.4.5 Austria Drug Repurposing Market Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2021 - 2031F |
7 Austria Drug Repurposing Market Import-Export Trade Statistics |
7.1 Austria Drug Repurposing Market Export to Major Countries |
7.2 Austria Drug Repurposing Market Imports from Major Countries |
8 Austria Drug Repurposing Market Key Performance Indicators |
9 Austria Drug Repurposing Market - Opportunity Assessment |
9.1 Austria Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
9.2 Austria Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.3 Austria Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Austria Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Austria Drug Repurposing Market - Competitive Landscape |
10.1 Austria Drug Repurposing Market Revenue Share, By Companies, 2024 |
10.2 Austria Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here